Oct
2026
Fiera Milano, Italy
Visit us
stand 20K50, Finished Dosage & Formulation
Zone
Hainan Zhonghe Pharmaceutical Co., Ltd.
Exhibitor at CPHI Milan 2026
About Us
Categories
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:1
-
Employees:250 - 499
Company types
Primary activities
Event information
CPHI Milan 2026
-
6 Oct 2026 - 8 Oct 2026
-
Fiera Milano, Italy
-
Visit us at stand 20K50, Finished Dosage & Formulation
Products Featured at CPHI Milan 2026
-
Product Entecavir Dispersible Tablets and Capsules
Strength: 0.5 mg Entecavir is used to treat chronic (long-term) hepatitis B infection (swelling of the liver caused by a virus) in adults and children 2 years of age and older who have liver damage. -
Product Eptifibatide Injection
Strength: 20 mg/10 ml It is used for the prevention of early myocardial infarction in adults presenting with unstable angina or non-Q-wave myocardial infarction, and for platelet aggregation -
Product Ganirelix Acetate Injection
Strength: 0.25 mg/0.5 ml. Ganirelix is a GnRH antagonist used in assisted reproduction in women undergoing controlled ovarian hyperstimulation to control ovulation by inhibiting the premature LH surges. -
Product Atosiban Acetate Injection
Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant to halt premature labor. Atosiban Acetate Injection is indicated to delay imm... -
Product Bivalirudin for Injection
It is s indicated for use as an anticoagulant in patients with unstable angina undergoing percutaneous transluminal coronary angioplasty (PTCA).




